Suchergebnisse - "Bettiol, Alessandra"

PubPharm (6)

1

Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus : post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al

enthalten in: Annals of the rheumatic diseases | 2022

von Bettiol, A. | Pregnolato, F. | Sciascia, S. | +3

CommentOn: Ann Rheum Dis. 2020 Feb;79(2):304-307. - PMID 31712248

2

Comment on : Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. Reply

enthalten in: Rheumatology (Oxford, England) | 2021

von Bettiol, A. | Mattioli, I. | Emmi, G. | +2

CommentOn: Rheumatology (Oxford). 2020 Dec 1;59(12):3709-3716. - PMID 32388557

3

Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome : A case series and systematic review of literature

enthalten in: Autoimmunity reviews | 2020

von Urban, M. | Bettiol, A. | Serena, C. | +10

4

Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment

enthalten in: Autoimmunity reviews | 2019

von Emmi, G. | Bettiol, A. | Palterer, B. | +4

CommentOn: Ann Rheum Dis. 2018 Nov;77(11):1694-1695. - PMID 29776976

5

Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity : A cross-sectional study

enthalten in: International journal of cardiology | 2019

von Di Minno, M. | Emmi, G. | Ambrosino, P. | +8

6

The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies

enthalten in: Atherosclerosis | 2018

von Di Minno, M. | Scalera, A. | Tufano, A. | +5

1
[1]